The global Oncology Drugs market research is an intelligence report announced by Absolute Markets Insights. The erudite market study provides insightful data for readers to help them in making informed business decisions. Primary and secondary research methodologies have also been used to discover the correct and applicable data of Oncology Drugs market. Effective business strategies of key market players and of new startup industries are also studied thoroughly to provide extensive market knowledge. The report makes use of an effective analysis technique such as SWOT and Porter’s five analysis to present its accurate results on the market.

This analytical report is a precise piece of work that is gathered by studying different static as well as dynamic aspects of the businesses. Numerous graphical presentation techniques such as infographics, charts, ample graph, tables, and pictures have been used while curating this applicable report. The global opportunity and innovative trends of the Oncology Drugs market have been explored by analysts.

Top Key Players includes: F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Eli Lilly and Company, Novartis AG, Pfizer Inc., Bayer AG, AstraZeneca, Merck & Co., Inc.,CELGENE CORPORATION and Polaris Pharmaceuticals amongst others

For More Information Click@ https://www.absolutemarketsinsights.com/reports/Oncology-Drugs-Market-2019-2027-273

Key Findings of the Report:

In terms of revenue, global oncology drugs market was valued at US$ 119 billion in 2020. The introduction and approval of anti-PD-1 agents’ nivolumab and pembrolizumab for NSCLC has bought a new era for the cancer industry.
The number of patients receiving single-agent chemotherapy decreased considerably in the recent past and the patients who received EGFR-TKI based therapy also reduced substantially
Single drug therapies coupled with monoclonal antibodies against programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) have shown little efficacy in patients suffering from metastatic breast cancer. The same is low number of tumour-infiltrating lymphocytes, found in most of the breast cancers. As a result, the development of combinations of molecularly targeted therapies and immunotherapy have proven to be a great success.
The China and United States hold the leading positions in the cancer cell therapy pipeline. The number for the same are 439 and 305 agents respectively. Majority of the drugs developed in the United States are at pre-clinical stage, whereas the drugs that are being developed in China are at clinical stages
In August, 2019, the U.S. FDA granted approval to Rozlytrek. This drug is for adoslescents and adult who are suffering from genetic cancer defects. This drug got approval for treating diseases like NTRK (neurotrophic tyrosine receptor kinase) gene fusion. The drug has a unique ability to shrink tumors and has been evaluated in four clinical trials, studying the adults who are suffering from NTRK fusion-positive tumors.
Oncology Drugs Market Segmentation:

By Indication

Breast Cancer
Prostate Cancer
Basal Cell Cancer
Skin Cancer (Non-Melanoma)
Colorectal cancer
Lung Cancer
Renal Cancer
Bladder Cancer
Lymphoma
Others
By Treatment

Drug Therapies
Antimetabolites
Antitumor Antibiotics
Asparagine-Specific Enzymes
Bisphosphonates & Biosimilars
DNA-Damaging Agents (Antineoplastics) and Alkylating Agents
Inhibitors
DNA-Repair Enzyme Inhibitors
Histone Deacetylase Inhibitors
Janus-Associated Kinase (JAK) Inhibitors
Phosphoinositide 3-kinase inhibitors (PI3K inhibitors)
Proteasome Inhibitors
Tyrosine Kinase Inhibitors
PD-1 and PD-L1 inhibitors
Others
Monoclonal Antibodies
Others
Surgery
Open Surgery
Minimally Invasive Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Chimeric antigen receptor (CAR) T-cell therapy
Cytokine Treatment
Donor lymphocyte infusion
Monoclonal Antibody Treatment
Others
Targeted Therapy
Hormone Therapy
Stem Cell Transplant
Autologous stem cell transplantation
Allogeneic stem cell transplantation
Reduced-Intensity Allogeneic Stem Cell Transplantation
Graft-Versus-Host Disease
Precision Medicine
Others
By Region

North America
Europe
Asia Pacific
Middle East and Africa
Latin America
Contact Us:

Company: Absolute Markets Insights
Email id: [email protected]
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
Website: https://www.absolutemarketsinsights.com/